David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
GFL Environmental
GFL
$14.7B
| $18M | 0.01% |
431,608
+208,362
| +93% | +$8.91M |
|
1152
Zions Bancorporation
ZION
$9.86B
| $18M | 0.01% |
312,096
-59,592
| -16% | -$3.51M |
|
1153
CALL
Unity
U
$19.8B
| $18M | 0.01% |
819,500
-120,900
| -13% | -$3.35M |
|
1154
Johnson Controls International
JCI
$85.9B
| $17.9M | 0.01% |
136,986
-135,779
| -50% | -$17.5M |
|
1155
Sabra Healthcare REIT
SBRA
$5.32B
| $17.9M | 0.01% |
932,058
+275,680
| +42% | +$5.43M |
|
|
ESPR
1156
DELISTED
Esperion Therapeutics
ESPR
| $17.9M | 0.01% |
6,540,785
-362,698
| -5% | -$1.15M |
|
1157
Healthcare Realty
HR
$6.65B
| $17.9M | 0.01% |
1,054,779
+680,035
| +181% | +$11.9M |
|
1158
Hyatt Hotels
H
$16.7B
| $17.9M | 0.01% |
124,567
+109,238
| +713% | +$17.3M |
|
1159
Replimune Group
REPL
$1.49B
| $17.9M | 0.01% |
2,336,528
-238,514
| -9% | -$1.82M |
|
1160
Omnicell
OMCL
$1.52B
| $17.8M | 0.01% |
534,611
-377,343
| -41% | -$15.8M |
|
1161
PUT
Baidu
BIDU
$31.7B
| $17.8M | 0.01% |
160,000
-611,900
| -79% | -$83M |
|
1162
BioNTech
BNTX
$28.6B
| $17.8M | 0.01% |
199,768
-288,784
| -59% | -$29.7M |
|
1163
Rayonier Advanced Materials
RYAM
$582M
| $17.6M | 0.01% |
1,594,055
+55,670
| +4% | +$502K |
|
1164
Meritage Homes
MTH
$4.79B
| $17.6M | 0.01% |
285,336
+117,076
| +70% | +$8.27M |
|
1165
iShares US Medical Devices ETF
IHI
$3.44B
| $17.6M | 0.01% |
329,189
+292,088
| +787% | +$17.2M |
|
1166
Regeneron Pharmaceuticals
REGN
$85.8B
| $17.6M | 0.01% |
22,730
-132,745
| -85% | -$102M |
|
1167
Collegium Pharmaceutical
COLL
$852M
| $17.6M | 0.01% |
530,698
-123,176
| -19% | -$5.22M |
|
1168
Ormat Technologies
ORA
$6.53B
| $17.5M | 0.01% |
156,353
-45,384
| -22% | -$5.27M |
|
1169
Avis
CAR
$5.13B
| $17.5M | 0.01% |
119,825
-80,455
| -40% | -$9.17M |
|
1170
PUT
Flutter Entertainment
FLUT
$17.7B
| $17.4M | 0.01% |
171,100
+156,900
| +1,105% | +$22.6M |
|
1171
IAMGOLD
IAG
$12.7B
| $17.4M | 0.01% |
925,673
-1,157,941
| -56% | -$23M |
|
1172
Equifax
EFX
$22.5B
| $17.4M | 0.01% |
+96,685
| New | +$19.2M |
|
1173
WaFd
WAFD
$2.68B
| $17.3M | 0.01% |
551,847
+193,949
| +54% | +$6.24M |
|
1174
PUT
Humana
HUM
$46.8B
| $17.3M | 0.01% |
99,900
-89,600
| -47% | -$18.4M |
|
1175
Sensient Technologies
SXT
$5.82B
| $17.3M | 0.01% |
200,281
-3,230
| -2% | -$302K |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.